Cromos Pharma, where the patients are

United States

Fred Hutchinson, Memorial Sloan-Kettering team up to launch Juno Therapeutics

Thursday, December 5, 2013 10:49 AM

The Fred Hutchinson Cancer Research Center (Fred Hutch) and Memorial Sloan-Kettering Cancer Center (MSKCC), along with pediatric partner Seattle Children’s Research Institute, have joined forces to launch Juno Therapeutics, a new biotechnology company focused on bringing forward novel immunotherapies for cancer.

More... »

CRF Health eCOA webinar series

New research shows promise for possible HIV cure

Wednesday, December 4, 2013 02:33 PM

Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection. Results of the study were presented at the annual meeting of the Radiological Society of North America (RSNA).

More... »


Cord Blood Registry, U.S. Women's Health Alliance partner

Wednesday, December 4, 2013 01:02 PM

Cord Blood Registry (CBR), a newborn stem cell company, and the U.S. Women's Health Alliance have partnered on a nationwide patient education and quality initiative to ensure all expectant parents understand their options regarding umbilical cord stem cell collection and possibly improve medical outcomes for their families.

More... »

NIH plans $100 million funding increase for HIV/AIDS research

Wednesday, December 4, 2013 01:01 PM

The NIH plans to redirect AIDS research funds to expand support for research directed toward a cure for HIV. NIH plans to invest an additional $100 million over the next three fiscal years on this area of HIV/AIDS research.

More... »

Report: Pharma should factor medication adherence into drug development

Monday, December 2, 2013 10:34 AM

Decision Resources, a research and advisory firm for pharmaceutical and healthcare issues, has a new strategic insights report that found in response to widespread medication nonadherence, pharmaceutical companies should factor medication adherence interventions into their drug development process.

More... »

The CenterWatch Monthly, December 2013

Monday, December 2, 2013 08:01 AM
Summary not available

More... »

NYSCF, NIH to use stem cells to model rare diseases

Wednesday, November 27, 2013 11:49 AM

The New York Stem Cell Foundation (NYSCF) Research Institute is partnering with the National Institutes of Health (NIH) Undiagnosed Disease Program (UDP). NYSCF scientists will generate stem cell lines from 100 patients in the UDP and collaborate with UDP researchers to better understand and potentially treat select rare diseases.

More... »

Novartis, Pfizer, Eli Lilly partner to enhance ClinicalTrials.gov

Monday, November 25, 2013 02:04 PM

Developing new treatments for diseases depends on clinical research studies and 57% of Americans say they would be interested in participating in a clinical trial. However, almost half of all studies never reach their recruitment targets.

More... »

Chicago Hospitals awarded NIH grant to accelerate stroke research, treatments

Friday, November 22, 2013 12:50 PM

A new network dedicated to advancing research and therapies for stroke is forming in Chicago after receiving $2 million in grants from the NIH. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital of Cook County, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center and University of Chicago Medicine. It will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery. Northwestern University will be the regional coordinating center for the consortium and administer the project over the next five years.

More... »

GHS Cancer Institute, USC School of Medicine partner

Friday, November 22, 2013 12:39 PM

The Greenville Health System’s Human Performance Laboratory, expected to open January, is the first HPL in the nation to be fully embedded into a cancer research and treatment program.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs